Fortive

Fortive (FTV) Stock Price, Fundamentals & Analysis

StockUSS&P 500Industrials

Price

56.26 USD

+0.55%

Price history

Over the past year FTV traded between 47.67 USD and 64.09 USD, closing at 56.26 USD on Sep 24, 2026.

Key statistics

Market cap17.15B USD
P/E ratio (TTM)29.8
Forward P/E17.3
EPS (TTM)1.89 USD
Dividend yield0.5%
Annual dividend0.28 USD
Ex-dividend dateSep 4, 2026
Payout ratio13%
52-week range47.31 – 64.56
52-week change16.2%
Beta0.97
Price / book2.81
Revenue (TTM)4.32B USD
Revenue growth (YoY)7.9%
Gross margin63.2%
Operating margin19.1%
Profit margin12.4%
Return on equity7.3%
Debt / equity59.3
Volume1,586,991
Average volume2,520,617
Next earningsOct 28, 2026
ExchangeNYSE

Profile

Sector
Technology
Industry
Scientific & Technical Instruments
Employees
10,000
Headquarters
Everett, United States

Fortive Corporation designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. It operates through Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including maintenance, repair, measurement and condition monitoring, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names.

Overview

What FTV does

Fortive (FTV) is a US stock in the Technology sector, specifically the Scientific & Technical Instruments industry, headquartered in Everett, United States. It designs, develops, manufactures, and markets products, software, and services in the United States, China, and internationally. Fortive operates through two segments: Intelligent Operating Solutions, which provides advanced instrumentation, software, and services under brands such as ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, and SERVICECHANNEL; and Advanced Healthcare Solutions, which offers critical workflow solutions under the ASP, CENSIS, FLUKE BIOMEDICAL, LANDAUER, and PROVATION brand names. With approximately 10,000 employees, it is part of the S&P 500.

Key numbers explained

  • The current price is 56.26 USD, up +0.55% today, with a 52-week range of 47.31 – 64.56 and a 16.2% price change over the last year.
  • The trailing P/E ratio of 29.8 shows how much investors pay per dollar of recent earnings, while the forward P/E ratio of 17.3 reflects expectations for future earnings.
  • The dividend yield is 0.5%, with 13% of trailing 12-month earnings paid out as dividends and an ex-dividend date of Sep 4, 2026.
  • Earnings per share (trailing 12 months) is 1.89 USD, and the beta of 0.97 suggests the stock's volatility is roughly in line with the overall market.
  • The debt-to-equity ratio of 59.3% indicates the proportion of debt relative to shareholders' equity, while the price-to-book ratio of 2.81 compares the market price to the company's book value.
  • Revenue (trailing 12 months) stands at 4.32 mld. USD, growing 7.9% year over year, with a profit margin of 12.4% and an operating margin of 19.1%.
  • The return on equity is 7.3%, and the next earnings date is Oct 28, 2026.

Recent news

Recent headlines highlight Fortive as a mid-cap stock under consideration, with some coverage noting challenges and mixed potential compared to peers. Other stories note that Fortive may be underperforming the Nasdaq, while Fluke expanded its iSee Mobile Series with new thermal and acoustic cameras. The company also announced the appointment of Susan Main to its Board of Directors.

What to watch

Investors tracking Fortive may look at how its revenue growth and operating margin evolve alongside broader trends in industrial technology and healthcare solutions. The forward P/E ratio and upcoming earnings date can signal how the market views future performance. As a component of the S&P 500, Fortive's movements may be compared with large-cap industrials such as J.B. Hunt (JBHT), Xylem Inc. (XYL), and FedEx (FDX), as well as with smaller peers like Leidos (LDOS) and Emcor (EME). For those interested in regional comparisons, Romanian-listed equivalents such as Grupul Industrial Electrocontact S.A. (ECT) and Electromagnetica SA (ELMA) offer a different market context.

Latest news & filings

Frequently asked questions

Does FTV pay a dividend?

Yes, Fortive pays a dividend with a yield of 0.5%. The ex-dividend date is Sep 4, 2026, and 13% of trailing 12-month earnings are distributed as dividends.

What is the FTV P/E ratio?

Fortive's trailing P/E ratio is 29.8, while the forward P/E ratio based on expected earnings is 17.3.

Where can I buy FTV?

FTV trades on the US market as a stock. You can buy it through any broker that offers access to US equities, and it is also tracked in portfolios via InvestPane.

What sector and industry is Fortive in?

Fortive is in the Technology sector, specifically the Scientific & Technical Instruments industry.

When is Fortive's next earnings date?

The next earnings date for Fortive is Oct 28, 2026.

How has FTV performed over the last 52 weeks?

Over the last 52 weeks, Fortive's price ranged from 47.31 to 64.56, representing a 16.2% price change from one year ago to now.

Track FTV in your portfolio

Hold FTV at XTB, IBKR, Tradeville, Revolut or Trading 212? InvestPane brings every broker into one dashboard — allocation, performance and dividends in one place.

Start free

Data as of Sep 23, 2026. Sources: Yahoo Finance, Bucharest Stock Exchange.

For information and education only — not investment advice. Prices may be delayed. The overview is generated with AI from the data shown on this page.